193 related articles for article (PubMed ID: 31694928)
1. Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls
Swale C; Bougdour A; Gnahoui-David A; Tottey J; Georgeault S; Laurent F; Palencia A; Hakimi MA
Sci Transl Med; 2019 Nov; 11(517):. PubMed ID: 31694928
[No Abstract] [Full Text] [Related]
2. JTE-607, a multiple cytokine production inhibitor, targets CPSF3 and inhibits pre-mRNA processing.
Kakegawa J; Sakane N; Suzuki K; Yoshida T
Biochem Biophys Res Commun; 2019 Oct; 518(1):32-37. PubMed ID: 31399191
[TBL] [Abstract][Full Text] [Related]
3. Cryptosporidiosis Drug Discovery: Opportunities and Challenges.
Manjunatha UH; Chao AT; Leong FJ; Diagana TT
ACS Infect Dis; 2016 Aug; 2(8):530-7. PubMed ID: 27626293
[TBL] [Abstract][Full Text] [Related]
4. Anticancer benzoxaboroles block pre-mRNA processing by directly inhibiting CPSF3.
Tao Y; Budhipramono A; Huang J; Fang M; Xie S; Kim J; Khivansara V; Dominski Z; Tong L; De Brabander JK; Nijhawan D
Cell Chem Biol; 2024 Jan; 31(1):139-149.e14. PubMed ID: 37967558
[TBL] [Abstract][Full Text] [Related]
5.
Graham ML; Li M; Gong AY; Deng S; Jin K; Wang S; Chen XM
Front Immunol; 2023; 14():1205468. PubMed ID: 37346046
[No Abstract] [Full Text] [Related]
6. RNA-Based Therapy for Cryptosporidium parvum Infection: Proof-of-Concept Studies.
Castellanos-Gonzalez A; Sadiqova A; Ortega-Mendez J; White AC
Infect Immun; 2022 Jul; 90(7):e0019622. PubMed ID: 35647663
[No Abstract] [Full Text] [Related]
7. Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better.
Caravedo MA; White AC
Expert Rev Anti Infect Ther; 2023 Feb; 21(2):167-173. PubMed ID: 36533398
[TBL] [Abstract][Full Text] [Related]
8. A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors.
Jumani RS; Hasan MM; Stebbins EE; Donnelly L; Miller P; Klopfer C; Bessoff K; Teixeira JE; Love MS; McNamara CW; Huston CD
Nat Commun; 2019 Apr; 10(1):1862. PubMed ID: 31015448
[TBL] [Abstract][Full Text] [Related]
9. Opportunities and Challenges in Developing a
Jumani RS; Blais J; Tillmann HC; Segal F; Wetty D; Ostermeier C; Nuber N; Lakshman J; Aziz N; Chandra R; Chen WH; Chappell CL; Diagana TT; Manjunatha UH
ACS Infect Dis; 2021 May; 7(5):959-968. PubMed ID: 33822577
[TBL] [Abstract][Full Text] [Related]
10. Target Identification of an Antimalarial Oxaborole Identifies AN13762 as an Alternative Chemotype for Targeting CPSF3 in Apicomplexan Parasites.
Bellini V; Swale C; Brenier-Pinchart MP; Pezier T; Georgeault S; Laurent F; Hakimi MA; Bougdour A
iScience; 2020 Dec; 23(12):101871. PubMed ID: 33336164
[TBL] [Abstract][Full Text] [Related]
11. Novel treatment strategies and drugs in development for cryptosporidiosis.
Chavez MA; White AC
Expert Rev Anti Infect Ther; 2018 Aug; 16(8):655-661. PubMed ID: 30003818
[TBL] [Abstract][Full Text] [Related]
12. CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcoma.
Ross NT; Lohmann F; Carbonneau S; Fazal A; Weihofen WA; Gleim S; Salcius M; Sigoillot F; Henault M; Carl SH; RodrÃguez-Molina JB; Miller HR; Brittain SM; Murphy J; Zambrowski M; Boynton G; Wang Y; Chen A; Molind GJ; Wilbertz JH; Artus-Revel CG; Jia M; Akinjiyan FA; Turner J; Knehr J; Carbone W; Schuierer S; Reece-Hoyes JS; Xie K; Saran C; Williams ET; Roma G; Spencer M; Jenkins J; George EL; Thomas JR; Michaud G; Schirle M; Tallarico J; Passmore LA; Chao JA; Beckwith REJ
Nat Chem Biol; 2020 Jan; 16(1):50-59. PubMed ID: 31819276
[TBL] [Abstract][Full Text] [Related]
13. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
[TBL] [Abstract][Full Text] [Related]
14. Cryptosporidium and cryptosporidiosis: the African perspective.
Aldeyarbi HM; Abu El-Ezz NM; Karanis P
Environ Sci Pollut Res Int; 2016 Jul; 23(14):13811-21. PubMed ID: 27126869
[TBL] [Abstract][Full Text] [Related]
15. Cryptic parasite revealed improved prospects for treatment and control of human cryptosporidiosis through advanced technologies.
Jex AR; Smith HV; Nolan MJ; Campbell BE; Young ND; Cantacessi C; Gasser RB
Adv Parasitol; 2011; 77():141-73. PubMed ID: 22137584
[TBL] [Abstract][Full Text] [Related]
16. Induction of a Long Noncoding RNA Transcript, NR_045064, Promotes Defense Gene Transcription and Facilitates Intestinal Epithelial Cell Responses against
Li M; Gong AY; Zhang XT; Wang Y; Mathy NW; Martins GA; Strauss-Soukup JK; Chen XM
J Immunol; 2018 Dec; 201(12):3630-3640. PubMed ID: 30446564
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis.
Zhang CX; Love MS; McNamara CW; Chi V; Woods AK; Joseph S; Schaefer DA; Betzer DP; Riggs MW; Iroh Tam PY; Van Voorhis WC; Arnold SLM
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0156021. PubMed ID: 34748385
[TBL] [Abstract][Full Text] [Related]
18. Induction of Inflammatory Responses in Splenocytes by Exosomes Released from Intestinal Epithelial Cells following
Wang Y; Shen Y; Liu H; Yin J; Zhang XT; Gong AY; Chen X; Chen S; Mathy NW; Cao J; Chen XM
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642905
[No Abstract] [Full Text] [Related]
19. Prevalence, molecular characteristics and risk factors for cryptosporidiosis among Iranian immunocompromised patients.
Izadi M; Jonaidi-Jafari N; Saburi A; Eyni H; Rezaiemanesh MR; Ranjbar R
Microbiol Immunol; 2012 Dec; 56(12):836-42. PubMed ID: 23088420
[TBL] [Abstract][Full Text] [Related]
20. [Human cryptosporidiosis and Cryptosporidium spp. in Haiti].
Raccurt CP; Brasseur P; Verdier RI; Li X; Eyma E; Stockman CP; Agnamey P; Guyot K; Totet A; Liautaud B; Nevez G; Dei-Cas E; Pape JW
Trop Med Int Health; 2006 Jun; 11(6):929-34. PubMed ID: 16772015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
